Interestingly, this study also used the MCA/RDA assay to identify methylation of TOX, among other genes, and reported exactly similar methylation of TOX in 3/4 (75%) breast cancer cell lines (3 of the cell lines are different from those used in our study) and 10/24 (42%) in primary breast tumors. This evidence concerns the gene TOX and breast cancer.